Cell Division Cycle Associated 8 Is a Key Regulator of Tamoxifen Resistance in Breast Cancer

PURPOSE: Breast cancer (BC) is one of the most common malignancies globally, and millions of women worldwide are diagnosed with BC every year. Up to 70% of BC patients are estrogen receptor (ER)-positive. Numerous studies have shown that tamoxifen has a significant therapeutic effect on both primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Dehai, Shi, Libo, Bu, Yuhui, Li, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597414/
https://www.ncbi.nlm.nih.gov/pubmed/31281726
http://dx.doi.org/10.4048/jbc.2019.22.e29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597414/
https://www.ncbi.nlm.nih.gov/pubmed/31281726
http://dx.doi.org/10.4048/jbc.2019.22.e29

Ejemplares similares